Kiniksa Pharmaceuticals International, plc (KNSA)
NASDAQ: KNSA · Real-Time Price · USD
44.71
-0.27 (-0.60%)
Feb 12, 2026, 4:00 PM EST - Market closed

KNSA Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
3,3891,4281,2341,0428111,203
Market Cap Growth
132.59%15.76%18.45%28.46%-32.59%98.17%
Enterprise Value
3,0461,2151,046848617840
Last Close Price
44.7119.7817.5414.9811.7717.67
PE Ratio
95.77-87.605.68--
Forward PE
30.7342.93----
PS Ratio
5.483.374.574.7321.04-
PB Ratio
6.303.262.812.634.383.86
P/TBV Ratio
6.523.382.932.764.893.86
P/FCF Ratio
33.3156.2093.67182.67--
P/OCF Ratio
32.9555.5992.76179.37--
EV/Sales Ratio
5.092.873.873.8516.02-
EV/EBITDA Ratio
76.85--69.62--
EV/EBIT Ratio
79.85--86.73--
EV/FCF Ratio
29.9547.8179.39148.64--
Debt / Equity Ratio
0.020.020.030.020.030.02
Debt / EBITDA Ratio
0.22--0.38--
Debt / FCF Ratio
0.100.390.931.04--
Asset Turnover
0.940.770.550.640.13-
Inventory Turnover
8.066.583.413.72--
Quick Ratio
3.272.843.584.484.1510.16
Current Ratio
3.853.304.345.164.3810.46
Return on Equity (ROE)
7.39%-9.85%3.37%63.10%-63.55%-60.07%
Return on Assets (ROA)
3.76%-5.15%-3.19%1.76%-33.63%-32.57%
Return on Capital Employed (ROCE)
6.50%-9.50%-5.40%2.40%-83.30%-49.50%
Earnings Yield
1.06%-3.02%1.14%17.60%-19.48%-13.42%
FCF Yield
3.00%1.78%1.07%0.55%-15.63%-11.37%
Buyback Yield / Dilution
-7.99%0.69%-2.13%-2.69%-10.89%-14.42%
Updated Oct 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q